Bio-repository of post-clinical test samples at the National Cancer Center Hospital (NCCH) in Tokyo

Japanese Journal of Clinical Oncology

Volumn 39, Issue 8, 2009, Pages 534-539

  Furuta, Koh ^a   Yokozawa, Karin ^a   Takada, Takako ^a   Kato, Hoichi ^a,b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

Author keywords

Bio bank; Bio repository; Clinical laboratory; Limited storage system; Post clinical test sample

Indexed keywords

ARTICLE; BLOOD EXAMINATION; CANCER CENTER; CANCER RESEARCH; CLINICAL DATA REPOSITORY; CLINICAL EVALUATION; DATA COLLECTION METHOD; ETHICS; INFORMATION PROCESSING; LEGAL ASPECT; ECONOMICS; HEALTH CARE FACILITY; HUMAN; JAPAN; LABORATORY DIAGNOSIS; METHODOLOGY; NEOPLASM; PATIENT SELECTION; STANDARD;

BIOLOGICAL SPECIMEN BANKS; CANCER CARE FACILITIES; HUMANS; NEOPLASMS; PATIENT SELECTION; RESEARCH DESIGN; SPECIMEN HANDLING; TOKYO;

EID: 68849132231     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp049     Document Type: Article

References (23)

1. Furuta K, Kato H, Tsuchiya R, Hirohashi S. A report of Bio-Sample Repository at the National Cancer Center Hospital (NCCH) in Tokyo. Cell Preserv Technol 2008;6:155 (abstract HSR9).
2. Ambrosone C, Nesline M, Davis W. Establishing a cancer center data bank and biorepository for multidisciplinary research. Cancer Epidemiol Biomarkers Prev 2006;15:1575-7.
3. Norgaard-Pedersen B, Hougaard DM. Storage policies and use of the Danish Newborn Screening Biobank. J Inherit Metab Dis 2007;30:530-6.
4. Donatella U, Monica N, Aldo CP, Cristina C, Giuseppe C, Paolo IG, et al. The CREST biorepository: A tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases. Cancer Epidemiol Biomarkers Prev 2008;17:3013-9.
5. Wiwanitkit V. Ethical concerns on the use of laboratory waste. J Med Assoc Thai 2007;90:1259-60.
6. Nakajima TE, Yamada Y, Hamano T, Furuta K, Gotoda T, Katai H, et al. Adipocytokine levels in gastric cancer patients - resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol 2009 doi: 10.1007/s00535-009-0063-5.
7. Matsubara J, Ono M, Negishi A, Ueno H, Okusaka T, Furuse J, et al. Identification of a predictive biomarker for hematological toxicities of gemcitabine. J Clin Oncol 2009;27:2261-8.
8. Onishi Y, Mori S, Higuchi A, Kim SW, Fukuda T, Heike Y, et al. Early detection of plasma cytomegalovirus DNA by real-time PCR after allogeneic hematopoietic stem cell transplantation. Tohoku J Exp Med 2006;210:125-35.
9. New Energy and Industrial Technology Development Organization (NEDO), Advanced Industrial Science and Technology (AIST), and Japanese Committee for Clinical Laboratory Standards (JCCLS). Research and development to promote the creation and utilization of an intellectual infrastructure. Development of reference materials for laboratory medicine (FY2007) final report; 2007. The Project Report from NEDO 2007 (in Japanese).
10. Fuji S, Kim SW, Fukuda T, Mori S, Yamasaki S, Morita-Hoshi Y, et al. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2008;14:510-7.
11. Pentz RD, Billot L, Wendler D. Research on stored biological samples: views of African American and White American cancer patients. Am J Med Genet A 2006;140:733-9.
12. Beskow LM, Dean E. Informed consent for biorepositories: Assessing prospective participants' understanding and opinions. Cancer Epidemiol Biomarkers Prev 2008;17:1440-51.
13. Schrohl AS, Wurtz S, Nielsen HJ, Sweep FCGJ, Brunner N. Banking of biological fluids for studies of protein biomarkers. Mol Cell Proteomics 2008;7:2061-6.
14. Skogstrand K, Ekelund CK, Thorsen P, Vogel I, Jacobsson B, Norgaard-Pedersen B, et al. Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. J Immunol Methods 2008;336:78-84.
15. Jackson C, Best N, Elliott P. UK Biobank Pilot Study: Stability of haematological and clinical chemistry analytes. Int J Epidemiol 2008;37(Suppl 1):i16-22.
16. Schmitz G, Aslanidis C, Liebisch G, Orso E. The Danubian Biobank project. Stud Health Technol Inform 2008;134:143-59.
17. Barnes R, Parisien M, Murphy L, Watson P. Influence of evolution in tumor biobanking on the interpretation of translational research. Cancer Epidemiol Biomarkers Prev 2008;17:3344-50.
18. Guder WG, Narayana S, Wisser H, Zawta B. Samples: From the Patient to the Laboratory: The Impact of Preanalytical Variables on the Quality of Laboratory Results. Darmstadt: GIT VERLAG 1996.
19. Riegman PH, Dinjens WN, Oosterhuis JW. Biobanking for interdisciplinary clinical research. Pathobiology 2007;74:239-44.
20. Troyer D. Biorepository standards and protocols for collecting, processing, and storing human tissues. Methods Mol Biol 2008; 441:193-220.
21. Biobanks will provide 'electronic specimens' for medical research, Science Centric, 12 February 2009. http://www.sciencecentric.com/news/ article.php?q=09021206-biobanks-will-provide-electronicspecimens- medical-research&goback=%2Eanh_113193.
22. National Cancer Institute, National Institute of Health, US Department of Health and Human Services. Best Practices for Biospecimens and Resources. http://biospecimens.cancer.gov/practices/.
23. ISBER (International Society for Biological and Environmental Repositories). 2008 best practices for repositories: Collection, storage, retrieval and distribution of biological materials for research. Cell Preserv Technol 2008;6:3-58.